Rep. Tom Tiffany Introduces Legislation to End Birthright Citizenship Loophole Being Explo...
Is This PA Congressional Candidate Already Living the D.C. Insider Lifestyle?
Roy Cooper Waged War on North Carolina's School Voucher Program, but Sent His...
Oregon Senate Committee Guts Gun Control Bill
President Trump Blasts Tucker Carlson: 'He’s Not MAGA'
GOP Rep Defends American Foreign Policy, Explains Why Operation Epic Fury Was Inevitable
Senator Tim Sheehy Helps to Forcibly Remove Crazed Protester During Senate Hearing
Wisconsin Congressional Candidate Rebecca Cooke Flees When Confronted About Her Stance on...
Zohran Mamdani Pledges Universal Child Care Services to Illegals Immigrants
Federal Court Sentences Illegal Alien to Prison for $343K SNAP Benefits Fraud
CENTCOM: U.S. Has Destroyed More Than 30 Iranian Ships
NY AG Letitia James Sues Video Game Maker Over Loot Boxes
New Jersey Man Pleads Guilty in $600M Nationwide Catalytic Converter Theft Ring
U.S. House Rejects Resolution to Stop Strikes on Iran
Juror Bribery Plot in Feeding Our Future Fraud Trial Leads to 57-Month Sentence
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos